- Home >
- U.S. >
- California >
- San Diego
Warning: This profiles contains records that have been removed from public view per our opt-out policy.
Intercept Pharmaceuticals Inc
Active San Diego, CA
Intercept Pharmaceuticals Inc Overview
Intercept Pharmaceuticals Inc filed as a Foreign Business Corporation in the State of New York on Tuesday, April 22, 2008 and is approximately eighteen years old, according to public records filed with New York Department of State. A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in. This does not necessarily mean that they are from outside the United States.
Sponsored
Learn More
D&B Reports Available for
Intercept Pharmaceuticals Inc
Network Visualizer
Advertisements
Key People
Who own Intercept Pharmaceuticals Inc
| Name | |
|---|---|
| Mark Pruzanski |
President
Chief Executive Officer
CEO
Director
|
| Jerome Durso |
President
|
| Sandip Kapadia |
Treasurer
CFO
|
| Paolo Fundaro |
Director
Chairman
|
| Barbara Duncan |
Treasurer
|
| Klaus Veitinger 1 |
Director
|
| Rachel McMinn |
Secretary
|
| Srinivas M. Akkaraju |
Director
|
| Jared Sblendorio |
Secretary
|
| Daniel Wlech |
Director
|
| Daniel Bradbury |
Director
|
| Nancy Miller-Rich |
Director
|
| Keith Gottesdiener |
Director
|
| Luca Benatti |
Director
|
| Paolo Fundar |
Director
|
| Gino Santini |
Director
|
| Dan Welch |
Director
|
| David Alexander Shapiro 1 |
Vice President
|
| Michael E. Taussi |
|
| Christian Weyer |
Executive Vice President
|
Showing 8 records out of 20
Corporate Filings for Intercept Pharmaceuticals Inc
California Secretary of State
| Filing Type: | Statement & Designation By Foreign Corporation |
|---|---|
| Status: | Active |
| State: | California |
| Foreign State: | Delaware |
| State ID: | 03482314 |
| Date Filed: | Thursday, June 21, 2012 |
| Registered Agent | National Corporate Research, Ltd. |
Florida Department of State
| Filing Type: | Foreign for Profit Corporation |
|---|---|
| Status: | Active |
| State: | Florida |
| State ID: | F15000001418 |
| Date Filed: | Thursday, April 2, 2015 |
New York Department of State
| Filing Type: | Foreign Business Corporation |
|---|---|
| Status: | Active |
| State: | New York |
| Foreign State: | Delaware |
| County: | NEW YORK |
| State ID: | 3661303 |
| Date Filed: | Tuesday, April 22, 2008 |
| DOS Process | C T Corporation System |
| Source Record | NY DOS |
Texas Secretary of State
| Filing Type: | Foreign For-Profit Corporation |
|---|---|
| Status: | Active In existence |
| State: | Texas |
| State ID: | 802356897 |
| Date Filed: | Tuesday, December 15, 2015 |
Nevada Secretary of State
| Filing Type: | Foreign Corporation |
|---|---|
| Status: | Active |
| State: | Nevada |
| Foreign State: | Delaware |
| State ID: | E0161002019-9 |
| Date Filed: | Tuesday, March 26, 2019 |
Corporate Notes
| Source | Date | Type | Note |
|---|---|---|---|
|
4/22/2008 | Name History/Actual | Intercept Pharmaceuticals, Inc. |
|
12/15/2015 | Application for Registration | |
|
12/31/2016 | Public Information Report (PIR) | |
|
12/31/2017 | Public Information Report (PIR) | |
|
12/31/2018 | Public Information Report (PIR) | |
|
12/31/2018 | Public Information Report (PIR) | |
|
3/26/2019 | Foreign Qualification | Initial Stock Value: Par Value Shares: 45,000,000 Value: $ 0.001 Par Value Shares: 5,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 50,000.00 |
|
3/26/2019 | Initial List | |
|
12/31/2019 | Public Information Report (PIR) | |
|
12/31/2019 | Public Information Report (PIR) | |
|
12/31/2020 | Public Information Report (PIR) | |
|
12/31/2022 | Public Information Report (PIR) |
Trademarks for Intercept Pharmaceuticals Inc
|
Serial Number:
87000712
Drawing Code: 4000
|
|
Serial Number:
87000670
Drawing Code: 4000
|
|
Serial Number:
87000735
Drawing Code: 4000
|
|
Serial Number:
87000755
Drawing Code: 4000
|
|
Serial Number:
86889874
Drawing Code: 4000
|
|
Serial Number:
86889891
Drawing Code:
|
|
Serial Number:
86516715
Drawing Code: 3000
|
|
Serial Number:
86516706
Drawing Code: 4000
|
|
Serial Number:
86813425
Drawing Code: 5000
|
|
Serial Number:
86813372
Drawing Code: 4000
|
Advertisements
Sources
Florida Department of State
Data last refreshed on Monday, April 6, 2026
Data last refreshed on Monday, April 6, 2026
New York Department of State
Data last refreshed on Saturday, October 12, 2024
Data last refreshed on Saturday, October 12, 2024
Nevada Secretary of State
Data last refreshed on Wednesday, May 8, 2019
Data last refreshed on Wednesday, May 8, 2019
California Secretary of State
Data last refreshed on Monday, April 4, 2022
Data last refreshed on Monday, April 4, 2022
Texas Secretary of State
Data last refreshed on Saturday, March 2, 2024
Data last refreshed on Saturday, March 2, 2024
What next?
Follow
Receive an email notification when changes occur for Intercept Pharmaceuticals Inc.
Notifications include:
- New company roles
- Change in active status
- Location updates
- New connections
Follow
Create Account
Create a free account to access additional details for Intercept Pharmaceuticals Inc and other profiles that you visit
Benefits include:
- Access to more records
- Full screen network visualizer
- Follow profiles
- See how people are connected
Advertisements
Wiki
5
Corporate Records